- 
MRK is a quality compounder selling at a discount.
Year | 2025 | 2026 | 2027 | 2028
EPS | 8.90 | 9.72 | 10.65 | 10.38
EPS% | 18.36% | 9.21% | 9.54% | -2.52%
Conservative forward p/e should be 10
Fair Stock value:
EPS | 8.90 | 9.72 | 10.65 | 10.38
Price | 89 | 97 | 106 | 103
Positive Suprises or rotation into healthcare by fund manager would leead to forward p/e of 15
EPS | 8.90 | 9.72 | 10.65 | 10.38
Stock price | 133 | 145 | 159 | 155
MRK is a quality compounder selling at a discount. Year | 2025 | 2026 | 2027 | 2028
EPS | 8.90 | 9.72 | 10.65 | 10.38
EPS% | 18.36% | 9.21% | 9.54% | -2.52%
Conservative forward p/e should be 10
Fair Stock value:
EPS | 8.90 | 9.72 | 10.65 | 10.38
Price | 89 | 97 | 106 | 103
Positive Suprises or rotation into healthcare by fund manager would leead to forward p/e of 15
EPS | 8.90 | 9.72 | 10.65 | 10.38
Stock price | 133 | 145 | 159 | 155
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.